| __timestamp | Corcept Therapeutics Incorporated | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 18372000 | 1595000 |
| Thursday, January 1, 2015 | 15419000 | 11434000 |
| Friday, January 1, 2016 | 23844000 | 26546000 |
| Sunday, January 1, 2017 | 40376000 | 39778000 |
| Monday, January 1, 2018 | 75247000 | 53418000 |
| Tuesday, January 1, 2019 | 89017000 | 111997000 |
| Wednesday, January 1, 2020 | 114764000 | 139507000 |
| Friday, January 1, 2021 | 113864000 | 195958000 |
| Saturday, January 1, 2022 | 130991000 | 248149000 |
| Sunday, January 1, 2023 | 184353000 | 232366000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Corcept Therapeutics Incorporated and ImmunityBio, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Corcept Therapeutics increased its R&D expenses by nearly 900%, starting from a modest $18 million in 2014 to a substantial $184 million in 2023. This growth reflects Corcept's strategic focus on expanding its research capabilities. Meanwhile, ImmunityBio, Inc. showcased an even more aggressive approach, with R&D spending skyrocketing from $1.6 million in 2014 to $232 million in 2023, marking an impressive 14,500% increase.
These figures highlight the dynamic nature of the biotech industry, where companies must continuously innovate to stay ahead. As these two companies forge their paths, their R&D investments will likely play a pivotal role in shaping their future successes.
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
R&D Insights: How Biogen Inc. and ImmunityBio, Inc. Allocate Funds
R&D Insights: How Neurocrine Biosciences, Inc. and Corcept Therapeutics Incorporated Allocate Funds
Viatris Inc. or ImmunityBio, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Corcept Therapeutics Incorporated
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Opthea Limited
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Veracyte, Inc.
ImmunityBio, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited